Daniel Bakken is currently the Vice President of Commercial Development for Vaccines at Pfizer, where they oversee the early commercial development of pipeline assets and market development strategies. With a strong background in strategic consulting, business development, and operations management within the pharmaceutical industry, Daniel has successfully managed an $850M research pilot plant and an $11M annual budget. They previously held various leadership roles at Pfizer, including Senior Director and Director, focusing on market access and strategic development for vaccine candidates. Daniel earned a BS in Chemical Engineering from Cornell University and an MBA in Data & Decision Models and Corporate Finance from NYU Stern School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices